LIU An-Chang, ZHAO Li-Xia, YU Shu-Wen, LOU Hong-Xiang. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats[J]. Chinese Journal of Natural Medicines, 2015, 13(4): 257-263.
Citation: LIU An-Chang, ZHAO Li-Xia, YU Shu-Wen, LOU Hong-Xiang. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats[J]. Chinese Journal of Natural Medicines, 2015, 13(4): 257-263.

Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats

  • The present study was designed to determine the effects of puerarin pre-treatment on the pharmacokinetics of the oral anticoagulant agent warfarin and the antiplatelet agent clopidogrel in rats. In the treatment group, rats was gavaged with warfarin or clopidogrel after repeated treatment with puerarin at intraperitoneal doses of 20, 60, or 200 mgkg-1 for 7 days, while rats in the control group were administrated only with the same dose warfarin or clopidogrel. Plasma samples were obtained at the prescribed times and analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS). The results showed that rats treated with puerarin at all the test doses of 20, 60 and 200 mgkg-1 were found to affect the pharmacokinetics of warfarin, but not clopidogrel, suggesting a potential herb-drug interaction between puerarin and warfarin.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return